Bio-Techne Corp
NASDAQ:TECH
Balance Sheet
Balance Sheet Decomposition
Bio-Techne Corp
Current Assets | 610.7m |
Cash & Short-Term Investments | 145.3m |
Receivables | 227.9m |
Other Current Assets | 237.5m |
Non-Current Assets | 2.1B |
PP&E | 341m |
Intangibles | 1.5B |
Other Non-Current Assets | 272.1m |
Current Liabilities | 149.8m |
Accounts Payable | 28.9m |
Accrued Liabilities | 75.1m |
Other Current Liabilities | 45.8m |
Non-Current Liabilities | 557m |
Long-Term Debt | 389m |
Other Non-Current Liabilities | 168m |
Balance Sheet
Bio-Techne Corp
Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
319
|
55
|
64
|
92
|
122
|
101
|
147
|
199
|
173
|
181
|
|
Cash Equivalents |
319
|
55
|
64
|
92
|
122
|
101
|
147
|
199
|
173
|
181
|
|
Short-Term Investments |
45
|
56
|
32
|
66
|
60
|
65
|
124
|
33
|
75
|
24
|
|
Total Receivables |
55
|
70
|
93
|
117
|
120
|
138
|
123
|
145
|
195
|
219
|
|
Accounts Receivables |
48
|
70
|
93
|
117
|
120
|
138
|
123
|
145
|
195
|
219
|
|
Other Receivables |
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
39
|
50
|
57
|
60
|
86
|
91
|
103
|
117
|
141
|
172
|
|
Other Current Assets |
12
|
18
|
8
|
13
|
11
|
18
|
24
|
17
|
23
|
27
|
|
Total Current Assets |
469
|
248
|
254
|
348
|
398
|
413
|
521
|
511
|
606
|
622
|
|
PP&E Net |
117
|
130
|
132
|
135
|
145
|
154
|
248
|
282
|
289
|
325
|
|
PP&E Gross |
117
|
130
|
132
|
135
|
145
|
154
|
248
|
282
|
289
|
325
|
|
Accumulated Depreciation |
93
|
109
|
114
|
128
|
140
|
152
|
170
|
190
|
211
|
234
|
|
Intangible Assets |
109
|
293
|
311
|
452
|
446
|
579
|
517
|
616
|
532
|
535
|
|
Goodwill |
152
|
391
|
431
|
579
|
598
|
733
|
728
|
843
|
822
|
873
|
|
Long-Term Investments |
14
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
2
|
2
|
2
|
44
|
5
|
6
|
14
|
12
|
47
|
285
|
|
Other Assets |
152
|
391
|
431
|
579
|
598
|
733
|
728
|
843
|
822
|
873
|
|
Total Assets |
863
N/A
|
1 063
+23%
|
1 130
+6%
|
1 558
+38%
|
1 593
+2%
|
1 884
+18%
|
2 028
+8%
|
2 263
+12%
|
2 295
+1%
|
2 639
+15%
|
|
Liabilities | |||||||||||
Accounts Payable |
10
|
13
|
21
|
17
|
19
|
16
|
23
|
29
|
34
|
26
|
|
Accrued Liabilities |
10
|
17
|
23
|
45
|
45
|
55
|
50
|
78
|
92
|
63
|
|
Short-Term Debt |
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
4
|
4
|
0
|
0
|
13
|
13
|
13
|
13
|
0
|
|
Other Current Liabilities |
1
|
5
|
7
|
74
|
16
|
18
|
21
|
32
|
38
|
40
|
|
Total Current Liabilities |
26
|
40
|
54
|
136
|
80
|
102
|
107
|
152
|
176
|
129
|
|
Long-Term Debt |
7
|
73
|
92
|
344
|
339
|
493
|
344
|
329
|
243
|
350
|
|
Deferred Income Tax |
34
|
61
|
63
|
121
|
86
|
90
|
101
|
93
|
99
|
89
|
|
Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
1
|
0
|
|
Other Liabilities |
0
|
42
|
42
|
9
|
9
|
34
|
94
|
118
|
75
|
105
|
|
Total Liabilities |
67
N/A
|
216
+222%
|
250
+16%
|
609
+143%
|
514
-16%
|
719
+40%
|
646
-10%
|
700
+8%
|
593
-15%
|
672
+13%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
Retained Earnings |
653
|
714
|
771
|
799
|
877
|
932
|
1 058
|
1 086
|
1 123
|
1 310
|
|
Additional Paid In Capital |
147
|
163
|
179
|
199
|
247
|
317
|
421
|
534
|
654
|
722
|
|
Unrealized Security Profit/Loss |
3
|
14
|
6
|
19
|
25
|
0
|
0
|
0
|
0
|
0
|
|
Other Equity |
9
|
45
|
65
|
68
|
70
|
84
|
97
|
57
|
75
|
66
|
|
Total Equity |
795
N/A
|
847
+6%
|
879
+4%
|
950
+8%
|
1 079
+14%
|
1 166
+8%
|
1 381
+18%
|
1 563
+13%
|
1 702
+9%
|
1 967
+16%
|
|
Total Liabilities & Equity |
863
N/A
|
1 063
+23%
|
1 130
+6%
|
1 558
+38%
|
1 593
+2%
|
1 884
+18%
|
2 028
+8%
|
2 263
+12%
|
2 295
+1%
|
2 639
+15%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
148
|
149
|
149
|
149
|
150
|
152
|
154
|
156
|
157
|
158
|